Correction for ‘Cost–utility analysis of MR imagingguided transurethral ultrasound ablation for the treatment of low- to intermediaterisk localised prostate cancer’
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/2/e088495corr1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost–utility analysis of MR imaging-guided transurethral ultrasound ablation for the treatment of low- to intermediate-risk localised prostate cancer
by: Stephanie Stock, et al.
Published: (2025-01-01) -
Sentinel lymph node biopsy in low- and intermediaterisk endometrial carcinoma
by: Christos Iavazzo, et al.
Published: (2025-05-01) -
P6 Short-term androgen deprivation therapy optimizes prostate anatomy for MRI-guided Transurethral Ultrasound Ablation (TULSA)
by: I. Virtanen, et al.
Published: (2025-07-01) -
1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
by: Mark Harris, et al.
Published: (2021-10-01) -
Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trial
by: Nicolas Barry Delongchamps, et al.
Published: (2024-12-01)